[134 Pages Report] The fermenters market was valued at USD 1.04 billion in 2017 and is projected to grow at a CAGR of 8.4% from 2018, to reach USD 1.69 billion by 2023. The basic objective of the report is to define, segment, and project the global market size of the market on the basis of application, mode of operation, microorganism, process, material, and region. It also helps to understand the structure of this market by identifying its various segments. The other objectives include analyzing the opportunities in the market for the stakeholders, providing the competitive landscape of the market trends, and projecting the size of the market and its submarkets, in terms of value.

For More details on this research, Request Free Sample Report

This research study involved the extensive use of secondary sources (which included directories and databases) such as Hoovers, Forbes, Bloomberg Businessweek, and Factiva to identify and collect information useful for this technical, market-oriented, and commercial study of the fermenters market. The primary sources that have been involved include industry experts from core and related industries and preferred suppliers, dealers, manufacturers, alliances, standards & certification organizations from companies, and organizations related to all segments of this industry�s value chain. In-depth interviews have been conducted with various primary respondents, such as key industry participants, subject matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology applied in drafting this report on the market.

To know about the assumptions considered for the study, download the pdf brochure

Key participants in the market are the fermenting equipment manufacturers, suppliers, and regulatory bodies. The key players that are profiled in the report include Eppendorf (Germany), Sartorius (Germany), Thermo Fisher Scientific (US), Pierre Guerin (France), CerCell ApS (Denmark), Electrolab Biotech (UK), Applikon Biotechnology (Netherlands), GEA Group (Germany), General Electric (US), Bioengineering AG (Switzerland), Zeta Holding (Austria), and bbi-biotech (Germany).

This report is targeted at the existing players in the industry, which include the following:

Fermenting equipment manufacturers

Regulatory bodies

Intermediary suppliers

Trade associations and industry bodies

Government and research organizations

�The study answers several questions for the stakeholders; primarily, which market segments to focus on in the next two to five years, for prioritizing efforts and investments.�

Drivers

Increased consumption of fermented beverages in developed economies

The rapid growing fermented beverage industry is expected to significantly drive the demand for fermenter systems and solutions during the forecast period, owing to the growing popularity of a variety of beers and wines in the emerging economies worldwide. According to the Brewer�s Association, in 2017, the craft beer sales continued to grow at a rate of about 5% by volume, which reached 12.7% of the US beer market, in terms of volume. According to the US Alcohol and Tobacco Tax and Trade Bureau (TTB) and US Commerce Department, 2018, the US beer industry, in 2017, exported about 207.4 million barrels of beer. According to the TTB and US Commerce, 2018, the US domestically produced about 83% of beer, and 17% of beer was imported from more than 100 different countries globally. According to TTB preliminary reports, the US recorded about 5,648 brewery production facilities in the region in 2017. According to the Brewers of Europe Organization, in 2016, Europe�s five countries recorded the highest growth in beer production, namely, Germany, the UK, Poland, Spain, and the Netherlands. Thus, the growing popularity of beer among consumers is expected to lead to the exponential growth in demand for fermented beverages, thereby increasing the demand for fermenters used for the fermentation of alcoholic beverages.

The global beer production volume reached 189 million kiloliters in 2015, of which Asia Pacific held a share of 33.8% of the global beer market in 2015. In 2015, China continued to be the largest beer producing country in the Asia Pacific region, followed by India and Vietnam.

Growing awareness about food preservation

Nowadays, fermentation is one of the most preferred methods of food preservation owing to the health benefits offered by this process. Fermented beverages such as mead, kvass, water kefir, dairy kefir, and kombucha are fermented and preserved by the fermentation process. During the fermentation, microorganisms produce lactic acid and acetic acid that are also known as bio-preservatives, which help in retaining the nutrients while also preventing food spoilage.

Restraints

Increasing cost of fermenters

Majorly, large-scale or commercial microbial or biopharmaceutical fermenters are always associated with high risks of contamination that occur during the fermentation process in large-scale production facilities. To avoid bacterial, fungal, and viral infections during microbial fermentations, fermenter producing manufacturers are incorporating sterilize-in-place and clean-in-place systems in fermenters, which result in high cost as the systems comprise highly polished stainless-steel material, thus ultimately resulting in the high cost of the fermenters.

Scope of the Report

The market has been segmented as follows:

On the basis of Application,

Food

Beverages

Healthcare & cosmetics

On the basis of Mode of Operation,

Semi-automatic

Automatic

On the basis of Microorganism,

Bacteria

Fungi

On the basis of Process,

Batch

Fed-batch

Continuous

On the basis of Region,

North America

Europe

Asia Pacific

South America

Rest of the World (RoW): This includes the Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to the company�s specific needs.

The following customization options are available for the report:

Segment Analysis

Product matrix, which gives a detailed comparison of the product portfolio of each company

Regional Analysis

Further breakdown of the Rest of Asia Pacific market for fermenters, by country

Further breakdown of the Rest of European market for fermenters, by country

Company Information

Detailed analysis and profiling of additional market players (up to five)

The fermenters market is estimated at USD 1.13 billion in 2018 and is projected to reach USD 1.69 billion by 2023, growing at a CAGR of 8.4% during the forecast period. The rise in application of fermentation technology in food, beverage, and pharmaceutical industries, along with the growing consumer perception regarding fermentation in terms of health claims, is the major factors spurring the demand for fermenters across the globe.

Based on process, the fed-batch fermenters dominated the market in terms of value. The application of these fermenters in extensive production of microbial cultures for various applications and production of mammalian cell culture systems are the main factors for the dominance of fed-batch systems in the market.

The beverage segment, by application, accounted for the largest share of the global market in 2017. With the increasing consumption of fermented beverages in the US and European countries, the production facilities of beer and wine have been increasing across the globe, which in turn reflects an increasing demand for fermenters. Beverage and food applications are projected to grow at a higher rate in the global market for fermenters, owing to the increasing adoption of fermentation technologies by key players for development of novel products.

Fermenters made using stainless steel, accounted for the largest share of the global market in 2017, by material. Owing to the advantages of reusability, increased durability, and ease in sanitization, stainless steel fermenters are increasingly preferred by end-use industries. Moreover, the adoption of stainless steel fermenters for large-scale production of metabolites in developed regions such as North America and Europe, contribute to the high demand for these fermenters in the market.

Asia Pacific is projected to be the fastest-growing market for fermenters during the forecast period. Emerging economies such as India have favorable market potential for fermented food products, which has led to food manufacturers in these countries adopting strategies such as expansions to cater to the demand and using fermenters to increase the production capacity of fermented products. Also, Asia Pacific is expanding as a leading region in the production of a variety of probiotic-based foods, beverages, and dietary supplements, along with innovations in the dessert, confectionery, and fermented food sectors. The growing population and per capita income in China, India, and Japan are expected to drive the demand for fermented foods & beverages, which, in turn, drive the demand for fermenters.

For More details on this research, Request Free Sample Report

One of the major restraining factors for the growth of the market is the high cost associated with large-scale fermenters. The high contamination risks associated with large-scale commercial, microbial, or biopharmaceutical fermenters are avoided by incorporating sterilize-in-place and clean-in-place systems in fermenters, which result in high cost. Also, manufacturers are preferring conical shaped fermenters for high-quality beverages, which are available at a higher price.

Players such as Eppendorf AG (Germany), Sartorius (Germany), Pierre Guerin SAS (France), and Applikon Biotechnology BV (Netherlands) have been actively strategizing their growth plans to expand in the fermenters market. These companies have a strong presence in Europe and North America, and also have manufacturing facilities across these regions and a strong distribution network.

Opportunities

Opportunities for fermented foods in emerging economies

With the reduced cost of production and preferred health benefits from fermented products, emerging economies such as China, India, and Thailand are majorly focusing on high utilization of fermentation technologies. According to the New Nutrition Business report on fermentation, many consumers in these economies are shifting their focus toward the consumption of fermented foods & beverages such as kombucha, kefir, teas, pickles, kimchi, and tempeh. For instance, Rhythm Health is producing a non-dairy kefir shot beverage, which is 100% natural with no added sugar and preservatives.

Technological innovations in fermenters

Fermentation extends the shelf life and improves the texture & product quality of food products such as yogurt, breads, and sauerkraut, beverages such as kefir, beer, and wines, and healthcare products. Fermenter equipment manufacturers have started investing in R&D, which has led to several effective fermentation technologies being introduced in the market in recent years. For instance, in 2016, Eppendorf AG launched a stirred tank and rigid wall bioreactor/fermenter for microbial fermentation. The product has favorable scalability and helps in reducing damage during installations.

Challenges

Complications associating with the cultivation of mammalian cell culture for the healthcare industry

The fermentation process is widely used in the healthcare industry to produce a variety of products such as antibiotics, ethanol, anti-viral drugs, mammalian cells, monoclonal antibodies, and therapeutic recombinant DNA and proteins. There is an increased demand for the cultivation of mammalian cells to produce biologics for therapeutic and diagnostics in the healthcare industry. Although there is an increased demand for mammalian cell culture in fermenters for the healthcare industry, there are a few drawbacks related to mammalian cell fermenters. For instance, the cells might end up not producing the desired products efficiently. Apart from this, the cultivation of mammalian cells requires a complex media, which further adds to the cost of mammalian cell culture fermenters. Thus, complications associated with mammalian cell culture are expected to limit the growth prospects for fermenter manufacturers in the healthcare industry.

Expansions, 2015�2017

Date Company Description October 2017 Eppendorf Eppendorf expanded the training center at its facility in Chennai, India. The facility consisted of a laboratory, which was equipped with research products such as sample handling, cell handling, and liquid handling. This enhanced the company�s position in India, along with demonstrating its product and service capabilities to its customers based in India. September 2017 Sartorius Sartorius expanded its biopharmaceutical and laboratory equipment production facility by investing around USD 45.5 million in Germany.

Acquisitions, 2015�2017

Date Company Description April 2017 Sartorius Sartorius, through its subsidiary Sartorius Stedim Biotech, acquired MKS Instruments AB (Umetrics) (Sweden), a leading company in data analytics software and biopharmaceutical manufacturing process. Sartorius acquired Umetrics for USD 72.5 million from MKS Instruments Group. March 2017 Sartorius Sartorius acquired Essen BioScience (US), a leading company in bioprocess data analytics software. Through this acquisition, the Sartorius lab products & services division expanded its portfolio in bioanalytics.

New Product Launches, 2015�2018

Date Company Description March 2018 Sartorius Sartorius Stedim Biotech launched ambr 250 high throughput fermenter/bioreactor for single-use perfusion system, which consisted of parallel bioreactor system. It was specifically designed for cell culture perfusion process to produce therapeutic antibodies. May 2017 Eppendorf Eppendorf launched the BioFlo 120, a fermenter system (bioprocess control station) for microbial fermentation and mammalian cell culture applications. It consisted of a wide range of glass and BioBLU single-use vessel options (250 mL to 40 L).

Agreements, Partnerships and Collaborations, 2015�2018

Date Company Description April 2018 Sartorius Sartorius Stedim Biotech and Pennsylvania State University (US) entered into a collaborative partnership, in which Sartorius would invest in the fermentation facility and a central laboratory to enhance the fermentation facility in Penn State�s Center of Excellence in Industrial Biotechnology (CoEIB) in the US. February 2017 GEA Group GEA Group agreed to provide two media preparation production lines and identical fermentation to Hanmi Pharmaceutical, a drug manufacturer in Korea. It also included production lines for insulin, which consisted of centrifugal separators, homogenizers, fermenters, and flow components, along with fully equipped GEA VESTA aseptic valves for the producing human immunoglobulin type G media.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst